Published in J Virol on July 18, 2007
Human host factors required for influenza virus replication. Nature (2010) 5.28
Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. J Virol (2008) 2.10
Influenza virus morphogenesis and budding. Virus Res (2009) 2.07
Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol (2007) 2.05
Broad protection against influenza infection by vectored immunoprophylaxis in mice. Nat Biotechnol (2013) 1.71
A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res (2011) 1.65
Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat Commun (2012) 1.64
One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proc Natl Acad Sci U S A (2012) 1.61
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol (2009) 1.50
Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. J Virol (2009) 1.40
A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. J Virol (2008) 1.37
Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol (2011) 1.35
At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol (2014) 1.33
Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication. J Virol (2009) 1.26
Rewiring the RNAs of influenza virus to prevent reassortment. Proc Natl Acad Sci U S A (2009) 1.25
Influenza virus reassortment occurs with high frequency in the absence of segment mismatch. PLoS Pathog (2013) 1.24
Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog (2013) 1.23
Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic Biol Med (2011) 1.21
Visualizing influenza virus infection in living mice. Nat Commun (2013) 1.20
The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin. Elife (2014) 1.18
Identification of potential conserved RNA secondary structure throughout influenza A coding regions. RNA (2011) 1.18
Protection against lethal influenza with a viral mimic. J Virol (2013) 1.18
Most influenza a virions fail to express at least one essential viral protein. J Virol (2013) 1.14
Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection. PLoS One (2012) 1.13
Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Rep (2013) 1.12
The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging. J Virol (2012) 1.12
Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment. J Virol (2010) 1.10
An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus. Nucleic Acids Res (2012) 1.10
A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins. J Virol (2010) 1.07
Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences. J Gen Virol (2009) 1.07
A functional sequence-specific interaction between influenza A virus genomic RNA segments. Proc Natl Acad Sci U S A (2013) 1.06
Characterisation of influenza A viruses with mutations in segment 5 packaging signals. Vaccine (2009) 1.04
High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution. Sci Rep (2014) 1.03
Genomic analysis of codon, sequence and structural conservation with selective biochemical-structure mapping reveals highly conserved and dynamic structures in rotavirus RNAs with potential cis-acting functions. Nucleic Acids Res (2010) 1.02
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses. Proc Natl Acad Sci U S A (2013) 1.00
The genome-packaging signal of the influenza A virus genome comprises a genome incorporation signal and a genome-bundling signal. J Virol (2013) 0.98
Influenza A and B virus intertypic reassortment through compatible viral packaging signals. J Virol (2014) 0.97
Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration. J Virol (2014) 0.94
Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus. J Virol (2007) 0.94
New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions. Antiviral Res (2013) 0.92
Transport of the influenza virus genome from nucleus to nucleus. Viruses (2013) 0.91
Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin. Viruses (2016) 0.89
Influenza A virus polymerase is a site for adaptive changes during experimental evolution in bat cells. J Virol (2014) 0.89
Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity. J Virol (2012) 0.89
Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules. J Virol (2011) 0.88
Competitive incorporation of homologous gene segments of influenza A virus into virions. J Virol (2012) 0.88
Taming influenza viruses. Virus Res (2011) 0.86
Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes. Virol J (2008) 0.86
Limited compatibility between the RNA polymerase components of influenza virus type A and B. Virus Res (2008) 0.86
A versatile RNA vector for delivery of coding and noncoding RNAs. J Virol (2013) 0.85
Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus. J Virol (2014) 0.82
New insights into the nonconserved noncoding region of the subtype-determinant hemagglutinin and neuraminidase segments of influenza A viruses. J Virol (2014) 0.80
Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Sci Rep (2017) 0.79
A conserved influenza A virus nucleoprotein code controls specific viral genome packaging. Nat Commun (2016) 0.79
The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expression. PLoS One (2013) 0.78
Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines. Future Virol (2015) 0.78
The Feat of Packaging Eight Unique Genome Segments. Viruses (2016) 0.77
Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA). Vaccine (2015) 0.77
Development and applications of single-cycle infectious influenza A virus (sciIAV). Virus Res (2015) 0.76
Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulation. PLoS One (2014) 0.76
Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells. Vaccine (2015) 0.76
A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein. ACS Infect Dis (2014) 0.76
Complete and Incomplete Genome Packaging of Influenza A and B Viruses. MBio (2016) 0.75
Protective immunity and safety of a genetically modified influenza virus vaccine. PLoS One (2014) 0.75
Incorporation of the influenza A virus NA segment into virions does not require cognate non-coding sequences. Sci Rep (2017) 0.75
Influenza A Virus Polymerase Recruits the RNA Helicase DDX19 to Promote the Nuclear Export of Viral mRNAs. Sci Rep (2016) 0.75
The dual roles of the HA segment-specific noncoding nucleotides in the extended duplex region of the influenza A virus RNA promoter. J Virol (2016) 0.75
Subtype-specific structural constraints in the evolution of influenza A virus hemagglutinin genes. Sci Rep (2016) 0.75
Influenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene. Viruses (2016) 0.75
Experimental Approaches to Study Genome Packaging of Influenza A Viruses. Viruses (2016) 0.75
Reverse Genetics Approaches for the Development of Influenza Vaccines. Int J Mol Sci (2016) 0.75
Epistatic Interactions within the Influenza A Virus Polymerase Complex Mediate Mutagen Resistance and Replication Fidelity. mSphere (2017) 0.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol (1999) 41.48
A monomeric red fluorescent protein. Proc Natl Acad Sci U S A (2002) 21.56
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
Amplification, expression, and packaging of foreign gene by influenza virus. Cell (1989) 11.21
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A (1990) 7.68
The genes of influenza virus. Cell (1977) 5.05
Differences in RNA patterns of influenza A viruses. J Virol (1976) 4.68
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol (2005) 4.16
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Counts of influenza virus particles. J Gen Microbiol (1954) 2.98
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60
cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J Virol (2005) 2.50
Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45
Correlation between RNA fragments of fowl plague virus and their corresponding gene functions. Virology (1976) 2.36
Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci (2001) 2.28
Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res (2007) 2.24
Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology (1996) 1.71
Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res (2003) 1.70
Complete sequence analyses show that two defective interfering influenza viral RNAs contain a single internal deletion of a polymerase gene. Proc Natl Acad Sci U S A (1982) 1.52
Evidence for segment-nonspecific packaging of the influenza a virus genome. J Virol (2002) 1.51
Origin of small RNA in von Magnus particles of influenza virus. J Virol (1979) 1.33
Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19
Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog (2007) 8.61
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog (2009) 6.09
Human host factors required for influenza virus replication. Nature (2010) 5.28
A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog (2007) 4.99
Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 4.74
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A (2008) 4.67
The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A (2006) 4.58
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26
Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol (2005) 4.16
Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio (2010) 4.15
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2004) 4.00
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog (2010) 3.89
Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A (2004) 3.85
High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J Virol (2008) 3.77
Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science (2012) 3.74
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog (2010) 3.08
Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol (2007) 3.04
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A (2012) 2.96
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol (2006) 2.78
Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A (2008) 2.72
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol (2008) 2.71
Newcastle disease virus V protein is a determinant of host range restriction. J Virol (2003) 2.61
The biology of influenza viruses. Vaccine (2008) 2.58
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
Pause on avian flu transmission research. Science (2012) 2.24
Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A (2006) 2.23
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2002) 2.21
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol (2007) 2.18
Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis (2009) 2.12
Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol (2013) 2.09
Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol (2012) 2.07
Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol (2007) 2.05
Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect Disord Drug Targets (2007) 2.04
PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol (2010) 2.01
Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol (2004) 1.98
Cellular proteins in influenza virus particles. PLoS Pathog (2008) 1.96
Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J Virol (2008) 1.95
Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol (2010) 1.92
A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol (2012) 1.90
Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med (2013) 1.84
The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol (2011) 1.82
Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol (2002) 1.81
A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. PLoS One (2012) 1.81
Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol (2010) 1.72
Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res (2003) 1.70
Unraveling the mystery of swine influenza virus. Cell (2009) 1.70
Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol (2013) 1.69
Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol (2005) 1.69
Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol (2008) 1.64
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol (2002) 1.63
One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proc Natl Acad Sci U S A (2012) 1.61
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog (2011) 1.60
In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol (2013) 1.59
Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J Virol (2010) 1.56
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol (2009) 1.50
Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol (2009) 1.50
Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med (2013) 1.49
Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe (2007) 1.49
Predictors of neurocognitive decline after carotid endarterectomy. Neurosurgery (2006) 1.49
H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol (2013) 1.48
A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine (2007) 1.48
Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog (2010) 1.46
An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic (2005) 1.44
A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol (2010) 1.44
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci U S A (2011) 1.42
1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. J Infect Dis (2012) 1.41
Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. J Virol (2012) 1.40
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun (2013) 1.37
A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. J Virol (2008) 1.37
Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol (2011) 1.35
Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc Natl Acad Sci U S A (2013) 1.34
Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr Top Microbiol Immunol (2015) 1.32
Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res (2008) 1.30
Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat Commun (2010) 1.29
Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol (2012) 1.29
Universal epitopes of influenza virus hemagglutinins? Nat Struct Mol Biol (2009) 1.29
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiol (2012) 1.28
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. J Clin Invest (2015) 1.27
Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol (2013) 1.26
Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. J Virol (2014) 1.26
Rewiring the RNAs of influenza virus to prevent reassortment. Proc Natl Acad Sci U S A (2009) 1.25
Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J Vis Exp (2013) 1.23
Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog (2013) 1.23
Transmission of influenza B viruses in the guinea pig. J Virol (2012) 1.22
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther (2009) 1.18
Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contact: a hypothesis. PLoS Curr (2009) 1.17
Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Res (2007) 1.17
7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase. J Virol (2006) 1.16